Precigen Revenue and Competitors
Estimated Revenue & Valuation
- Precigen's estimated annual revenue is currently $99M per year.
- Precigen's estimated revenue per employee is $942,667
- Precigen's total funding is $525.8M.
- Precigen's current valuation is $667.8M. (January 2022)
Employee Data
- Precigen has 105 Employees.
- Precigen grew their employee count by -1% last year.
Precigen's People
Name | Title | Email/Phone |
---|---|---|
1 | Pres & CEO | Reveal Email/Phone |
2 | SVP, Head Business Development | Reveal Email/Phone |
3 | SVP & Head Research | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | VP Human Resources | Reveal Email/Phone |
6 | SVP Regulatory Affairs | Reveal Email/Phone |
7 | SVP and Head CMC | Reveal Email/Phone |
8 | VP, Head Investor Relations | Reveal Email/Phone |
9 | SVP, Intellectual Property Affairs | Reveal Email/Phone |
10 | SVP, Intellectual Property Affairs (f/k/a Intrexon Corporation) | Reveal Email/Phone |
Precigen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Precigen?
DNA Sciences, Inc. is an applied genetics company focused on developing DNA diagnostics for critical medical and therapeutic decisions. The company utilizes DNA based tests in clinical trials to understand differential response to medication and diagnose disease state. It has a combination of research and GLP/CLIA facilities and is involved in a broad range of genetics activities extending from discovery and development to genetic testing services. DNA Sciences is also a leading provider of pharmacogenetic services to the pharmaceutical industry through its wholly-owned subsidiary, DNA Sciences Laboratories (formerly PPGx, Inc.). DNA Sciences is based in Fremont, Calif. and was founded in May 1998. Visit the company's website at www.dna.com.
keywords:N/A$525.8M
Total Funding
105
Number of Employees
$99M
Revenue (est)
-1%
Employee Growth %
$667.8M
Valuation
N/A
Accelerator
Precigen News
According to Zacks, analysts expect that Precigen will report full-year sales of $92.70 million for the current year, with estimates ranging...
Equities research analysts expect Precigen, Inc. (NYSE:PGEN Get Rating) to post $20.90 million in sales for the current quarter,...
Brokerages expect Precigen, Inc. (NYSE:PGEN Get Rating) to announce earnings per share of ($0.14) for the current fiscal quarter,...
GERMANTOWN, Md., Aug. 2, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release second quarter and first half 2021 financial r ...
GERMANTOWN, Md., Aug. 2, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release second quarter and first half 2021 financial ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.7M | 105 | 15% | N/A |
#2 | $23.8M | 105 | 5% | N/A |
#3 | $23.6M | 117 | 3% | N/A |
#4 | $29M | 118 | 12% | N/A |
#5 | $32.7M | 119 | -1% | N/A |